• Research
  • Discovery
  • Development
WIRF is one of Australia's leading organisations that is dedicated to improving the health of women and infants.

Matt Kemp

Matt Kemp

Head, WIRF Perinatal Research Laboratories
  • Matt completed his undergraduate studies in New Zealand at Otago University. He holds PhDs in Medicine (UNSW) and Education (UWA), and completed postdoctoral training at Oxford University with the support of an MRC Career Development Fellowship before being recruited to Perth in 2009 to lead the Foundation’s sheep-based perinatal research program. Matt is now an Associate Professor (Research), in the UWA Division of Obstetrics and Gynaecology.
     
    His research interests in perinatology are focused on improving outcomes for preterm infants, and include anti-inflammatory and antibiotic therapies, antenatal steroid treatment optimisation, and the development of an artificial uterine life support platform for extremely preterm infants.
     
    Matt’s work has been supported by a range of national and international agencies including the NHMRC, the NIH, the Bill and Melinda Gates Foundation, the Royal Society, the Ramaciotti Foundations and the Financial Markets Foundation for Children. Matt also works closely with a number of industry partners including GSK, Chiesi S.p.A and Nipro Corporation.
     
  • Matt has published 65 peer-reviewed papers in the past five years alone. His work has significantly advanced our understanding of how the fetus responds to infectious and inflammatory insults, how susceptibility to infection changes with gestation, and how common prematurity-associated infections can be targeted with antibiotic agents.

    Working with collaborators in the United States, his antenatal steroids studies have shown that current dosing strategies are likely excessive and demonstrated how modulated dosing can be used to deliver optimal preterm lung maturation.

    Working in collaborators in Japan, Matt’s studies with the artificial uterine life support platform for extremely preterm infants have generated national and international interest and are presently in an advanced phase of pre-clinical development.

    Matt also maintains an active interest in higher education, and has made a significant contribution to the empirical-based development of learning systems in doctoral education.

    • Antenatal steroid therapy optimisation
    • Antibiotic therapies in pregnancy
    • Antiinflammatory therapies in pregnancy
    • Ultrasound assessment of fetal cardiac function
    • WA Preterm Birth Prevention Initiative
    • 2017 Program for Leadership Development (PLD). Harvard Business School. Boston, MA.
    • 2015 Company Directors Course (GAICD). Australian Institute of Company Directors, Perth, Western Australia, Australia.
    • 2014 Doctor of Philosophy (PhD). Graduate School of Education, The University of Western Australia, Western Australia, Australia.
    • 2010 Postgraduate Diploma of Learning and Teaching in Higher Education (PgDipLATHE) Department of Education, The University of Oxford, UK.
    • 2006 Doctor of Philosophy (PhD). Department of Medicine, The University of New South Wales, New South Wales, Australia.
    • 2001 Postgraduate Diploma of Medical Laboratory Science (PgDipMLSc). Awarded with Distinction. Division of Health Sciences, The University of Otago, Otago, New Zealand.
    • 2001 Bachelor of Medical Laboratory Science (BMLSc). Division of Health Sciences, The University of Otago, Otago, New Zealand.
    • 2015 Honorary Associate Professor, Tohoku University School of Medicine, Sendai, Japan
    • 2015 Government of Western Australia, Department of Health Merit Award for NHMRC Project
    • 2015 Government of Western Australia, Department of Health Merit Award for NHMRC Fellowship
    • 2015 Japan Society for Obstetrics and Gynaecology International Session Oral Presentation Award. 67th Annual Meeting. April 9-12, Yokohama, Japan.
    • 2015 University of Western Australia, Dr Teck Jin Lian Memorial Prize in Education.
    • 2015 University of Western Australia, Cameron Prize in Education.
    • 2014 Visiting Fellowship, MRC Centre for Reproductive Health, Queen’s Institute for Medical Research, The University of Edinburgh. Edinburgh, UK.
    • 2013 International Society for Developmental Origins of Health and Disease, Prize for Best Poster. November 16-20, Singapore.
    • 2013 Society for Gynaecological Investigation, President’s (Pfizer) In-Training Award. March 18-21, Orlando, FL.
    • 2012 Western Australian Government Department of Health New Independent Investigator (NIRIS) Award.
    • 2012 University of Western Australia WAIER (Western Australian Institute for Education Research) Prize.
    • 2012 Japan Society for Obstetrics and Gynaecology International Session Oral Presentation Award. 64th Annual Meeting. April 13-15, Kobe, Japan.
    • 2012 Society for Gynaecological Investigation (SGI) New Investigator Award. 59th Annual Meeting. March 21-24, San Diego, CA.
       
    1. Kemp MW. Preterm birth, intrauterine infection, and fetal inflammation. Frontiers in immunology 2014;5.
    2. Kemp MW, Ahmed S, Beeton ML, et al. Foetal Ureaplasma parvum bacteraemia as a function of gestation‐dependent complement insufficiency: Evidence from a sheep model of pregnancy. American Journal of Reproductive Immunology 2017;77.
    3. Kemp MW, Miura Y, Payne MS, et al. Repeated maternal intramuscular or intraamniotic erythromycin incompletely resolves intrauterine Ureaplasma parvum infection in a sheep model of pregnancy. American journal of obstetrics and gynecology 2014;211:134. e1-34. e9.
    4. Kemp MW, Saito M, Usuda H, et al. Maternofetal pharmacokinetics and fetal lung responses in chronically catheterized sheep receiving constant, low-dose infusions of betamethasone phosphate. American journal of obstetrics and gynecology 2016;215:775. e1-75. e12.
    5. Usuda H, Watanabe S, Miura Y, et al. Successful maintenance of key physiological parameter in preterm lambs treated with ex vivo uterine environment therapy for a period of 1 week. American Journal of Obstetrics and Gynecology 2017.
For over 40 years, WIRF has conducted and supported research to improve the health of women and infants.

Sign up to our newsletter

Get the latest announcements, news and updates.

Contact details

Women and Infants Research Foundation
Carson House, King Edward Memorial Hospital
374 Bagot Road, Subiaco, WA 6008

Telephone: 08 6458 1437
Fax: 08 6458 1642
Email: info@wirf.com.au

Social Media